Recursion Pharmaceuticals (RXRX) is up 10.7%, or 62c to $6.46.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals rises 16.8%
- Unusually active option classes on open July 21st
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
- Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement